Answer
Jun 18, 2026 - 02:55 PM
Is Hadlima as Good as Humira?
Yes. Hadlima is expected to work as well as Humira for most people when used for the same approved condition. Hadlima contains adalimumab-bwwd and is a biosimilar to Humira, which contains adalimumab. A biosimilar is not a “weaker” version of the original biologic. It must be highly similar to the reference product and have no clinically meaningful differences in safety and effectiveness.
The official Hadlima label states that Hadlima is biosimilar to Humira, and Health Canada explains that approved biosimilars must show no clinically meaningful differences in safety and efficacy compared with their reference biologic.
Hadlima vs. Humira: What’s the Difference?
The main differences are usually practical, not clinical:
- Brand/manufacturer: Hadlima and Humira are made by different companies.
- Device: The pen or syringe may feel different.
- Cost and coverage: Insurance or provincial drug plans may prefer Hadlima.
- Formulation: Some versions may differ in concentration or inactive ingredients.
- Availability/substitution rules: In the U.S., Hadlima has received an FDAinterchangeability designation for Humira, meaning pharmacists may be able to substitute it depending on state law.
Does Hadlima Work the Same as Humira?
For most patients, Hadlima should provide the same treatment benefit as Humira. Both are adalimumab products used to treat inflammatory autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis. The Hadlima label lists these approved uses and identifies it as biosimilar to Humira.
Can I Switch From Humira to Hadlima?
Many people can switch from Humira to Hadlima without losing effectiveness, but the switch should be guided by your prescriber or pharmacist. After switching, track your symptoms, side effects, injection reactions, and any flare-ups for the first few months.
Bottom Line
Hadlima is not inferior to Humira. It is a biosimilar adalimumab product designed to provide the same clinical benefit for approved uses. The biggest differences are usually cost, coverage, injection device, and pharmacy substitution rules—not expected effectiveness.
Talk to your doctor or pharmacist before switching, especially if your condition has been stable on Humira or if you recently had a flare.
